Xencor (XNCR) – Management Comments
-
Xencor (XNCR) Tops Q1 EPS by 63c, Revenues Beat
-
Xencor (XNCR) Reports First Patient Dosing in Phase 1 Study of XmAb564
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to XNCR Stock Lookup